Helicobacter pylori infection: old and new

Area of Science:

• Gastroenterology
• Infectious Diseases
• Oncology

Background:

• Helicobacter pylori is a prevalent bacterium affecting over half the global population.
• Infection is associated with diverse clinical outcomes, from gastritis to gastrointestinal malignancies.
• H. pylori is found in over 75% of patients with mucosa-associated lymphoid tissue (MALT) lymphoma.

Purpose of the Study:

• To review the clinical significance of H. pylori infection.
• To discuss diagnostic methods and eradication strategies.
• To highlight the association of H. pylori with various diseases beyond the gastrointestinal tract.

Main Methods:

• Review of available literature on Helicobacter pylori detection and eradication.
• Analysis of the link between H. pylori and MALT lymphoma, ulcers, and other conditions.
• Discussion of diagnostic tests including antibody, urea breath, stool antigen tests, and biopsies.

Main Results:

• H. pylori eradication aids in preventing ulcer recurrence and is vital for MALT lymphoma treatment.
• Confirmation of eradication is recommended for ulcers, persistent dyspepsia, MALT lymphoma, and early gastric cancer.
• H. pylori infection is linked to hematologic disorders (ITP, iron deficiency anemia, B12 deficiency) and potentially neurodegenerative diseases.

Conclusions:

• H. pylori eradication is a key therapeutic strategy for specific conditions like MALT lymphoma and ulcer disease.
• Further research is needed to fully understand the association between H. pylori and neurodegenerative disorders, stroke, lung cancer, and preeclampsia.
• Diagnostic confirmation of eradication is essential in specific clinical scenarios to ensure treatment efficacy.